Polydeoxyribonucleotide stimulates angiogenesis and wound healing in the genetically diabetic mouse

Wound Repair and Regeneration

Volumn 16, Issue 2, 2008, Pages 208-217

  Galeano, Mariarosaria ^b   Bitto, Alessandra ^a   Altavilla, Domenica ^a   Minutoli, Letteria ^a   Polito, Francesca ^a   Calò, Margherita ^b   Lo Cascio, Patrizia ^b   Stagno D'Alcontres, Francesco ^b   Squadrito, Francesco ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3,7 DIMETHYL 1 PROPARGYLXANTHINE; ADENOSINE A2 RECEPTOR; ADENOSINE A2A RECEPTOR ANTAGONIST; ANGIOPOIETIN 1; BETA ACTIN; CD31 ANTIGEN; MESSENGER RNA; POLYDEOXYRIBONUCLEOTIDE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SKIN INJURY; TISSUE REGENERATION; WOUND HEALING; WOUND HEALING IMPAIRMENT;

ANGIOGENESIS INDUCING AGENTS; ANGIOPOIETIN-1; ANIMALS; ANTIGENS, CD34; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; GTP-BINDING PROTEINS; MICE; MICE, INBRED STRAINS; NEOVASCULARIZATION, PHYSIOLOGIC; POLYDEOXYRIBONUCLEOTIDES; TRANSGLUTAMINASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 40349113590     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2008.00361.x     Document Type: Article

References (33)

1. Stadelmann WK, Digenis AG, Tobin GR. Impediments to wound healing. Am J Surg 1998 176 : 39S 47S.
2. Dinh T, Pham H, Veves A. Emerging treatments in diabetic wound care. Wounds 2002 14 : 2 10.
3. Clark RA. Wound repair. Curr Opin Cellular Biol 1989 1 : 1000 8.
4. Risau W. Mechanisms of angiogenesis. Nature 1997 386 : 671 4.
5. Ansel JC, Tiesman JP, Olerud JE, Krueger JG, Krane JF, Tara DC, Shipley GD, Gilbertson D, Usui ML, Hart CE. Human keratinocytes are a major source of cutaneous platelet-derived growth factor. J Clin Investig 1993 92 : 671 8.
6. Folkman J, Shing T. Angiogenesis. J Biol Chem 1992 267 : 10931 4.
7. Shukla A, Dubey MP, Srivastava R, Srivastava BS. Differential expression of proteins during healing of cutaneous wounds in experimental normal and chronic models. Biochem Biophys Res Commun 1998 244 : 434 9.
8. Pierce GF, Tarpley JE, Tseng J, Bready J, Chang D, Kenney WC, Rudolph R, Robson MC, Vande Berg J, Reid P. Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence in PDGF in chronic nonhealing wounds. J Clin Investig 1995 96 : 1336 50.
9. Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF, van de Water L. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992 176 : 1375 9.
10. Ansel JC, Tiesman JP, Olerud JE, Krueger JG, Krane JF, Tara DC, Shipley GD, Gilbertson D, Usui ML, Hart CE. Human keratinocytes are a major source of cutaneous platelet-derived growth factor. J Clin Invest 1993 92 : 67.
11. Greenhalgh DG, Sprugel KH, Murraj MJ, Ross R. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol 1990 136 : 1235 46.
12. Coleman DL. Diabetes-obesity syndromes in mice. Diabetes 1982 31 (Suppl. 1) : 1 6.
13. Bohlen HG, Niggl BA. Adult microvascular disturbances as a result of juvenile-onset diabetes in db/db mice. Blood Vessels 1979 16 : 269 76.
14. Yue DK, McLennan S, Marsh M, Mai YW, Spaliviero J, Delbridge L, Reeve T, Turtle JR. Effects of experimental diabetes, uremia and malnutrition on wound healing. Diabetes 1987 36 : 295 9.
15. Goodson WH, Hunt TK. Studies of wound healing in experimental diabetes. J Surg Res 1977 22 : 221 7.
16. Altavilla D, Saitta A, Cucinotta D, Galeano M, Deodato B, Colonna M, Torre V, Russo G, Sardella A, Urna G, Campo GM, Cavallari V, Squadrito G, Squadrito F. Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis in the genetically diabetic mouse. Diabetes 2001 50 : 667 74.
17. Tonello G, Daglio M, Zaccarelli N, Sottofattori E, Mazzei M, Balbi A. Characterization and quantitation of the active polynucleotide fraction (PDRN) from human placenta, a tissue repair stimulating agent. J Pharmacol Biomed Anal 1996 14 : 1555 60.
18. Sini P, Denti A, Cattarini G, Daglio M, Tira ME, Balduini C. Effect of polydeoxyribonucleotides on human fibroblasts in primary culture. Cellular Biochem Function 1999 17 : 107 14.
19. Guizzardi S, Galli C, Govoni P, Boratto R, Cattarini G, Martini D, Belletti S, Scandroglio R. Polydeoxyribonucleotide (PDRN) promotes human osteoblast proliferation: a new proposal for bone tissue repair. Life Sci 2003 73 : 1973 83.
20. Rubegni P, De Aloe G, Mazzatenta C, Cattarini L, Fimiani M. Clinical evaluation of the trophic effect of polydeoxyribonucleotide (PDRN) in patients undergoing skin explants. A pilot study. Curr Med Res Opinion 2001 17 : 128 31.
21. Valdatta L, Thione A, Mortasino C, Buoro M, Tuinder S. Evaluation of the efficacy of polydeoxyribonucleotides in the healing process of autologous skin graft donor sites: a pilot study. Curr Med Res Opinion 2004 20 : 403 4.
22. Lazzarotto M, Tomasello EM, Caporossi A. Clinical evaluation of corneal epithelialization after photorefractive keratectomy in patients treated with polydeoxyribonucleitide (PDRN) eye drops: a randomized, double-blind, placebo-controlled trial. Europ J Ophthalmol 2004 14 : 284 9.
23. Thellung S, Florio T, Maragliano A, Cattarini G, Schettini G. Polydeoxyribonucleotides enhance the proliferation of human skin fibroblasts: involvement of A2 purinergic receptor subtypes. Life Sci 1999 64 : 1661 74.
24. Pierce GF, Mustoe TA, Senior RM, Reed J, Griffin GL, Thomason A, Deuel TF. In vivo incisional wound healing augmented by platelet-derived growth factor and recombinant c-sis gene homodimeric proteins. J Exp Med 1988 167 : 974 87.
25. Henning UGG, Wang Q, Gee NH, von Borstel RC. Protection and repair of γ-radiation-induced lesions in mice with DNA or deoxyribonucleoside treatments. Mutation Res 1996 350 : 247 54.
26. Bianchini P, Tellini N, Morani AM, Follano MG. Pharmacological data on polydeoxyribonucleotide of human placenta. Int J Tissue Reactions 1981 3 : 151 4.
27. Montesinos MC, Gadangi P, Longaker M, Sung J, Levine J, Nilsen D, Reibman J, Li M, Jiang CK, Hirschhorn R, Recht PA, Ostad E, Levin RI, Cronstein BN. Wound healing is accelerated by agonists of Adenosine A2 receptors. J Exp Med 1997 186 : 1615 20.
28. Nakamura E, Uezono Y, Narusawa K, Shibuya I, Oishi Y, Tanaka M, Yanagihara N, Nakamura T, Izumi F. ATP activates DNA synthesis by acting on P2X receptors in human osteoblast-like MG-63 cells. Am J Physiol Cell Physiol 2000 279 : C510 9.
29. Seale TW, Abla KA, Shamim MT, Carney JM, Daly JW. 3,7-Dimethyl-1- propargylxanthine: a potent and selective in vivo antagonist of adenosine analogs. Life Sci 1988 43 : 1671 84.
30. Montesinos MC, Desai A, Chen JF, Yee H, Schwarzschild MA, Fink JS, Cronstein BN. Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A(2A) receptors. Am J Pathol 2002 160 : 2009 18.
31. 2A receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis. Am J Pathol 2004 164 : 1887 92.
32. 2A receptor agonists and endotoxin. Am J Pathol 2002 160 : 2231 44.
33. Verderio EA, Johnson T, Griffin M. Tissue transglutaminase in normal and abnormal wound healing: review article. Amino Acids 2004 26 : 387 404.